16th November 2020

Consilium Strategic Communications, Citi Depositary Receipt Services, Cooley and Stifel host Virtual Annual Healthcare Conference today


  • Panel: The impact of COVID-19 on the future of healthcare

  • Fireside chat: The FT’s Clive Cookson speaks to Jan van de Winkel, President & Chief Executive Officer, Genmab

Follow the event on Twitter at: #CSCHealth2020

London, 16 November 2020, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, together with Citi Depositary Receipt Services, Cooley and Stifel is hosting its eighth Annual Healthcare Conference today, for the first time in a virtual format.


The event will once again bring together senior representatives from across the international healthcare and investment sectors to share their insights on key industry topics and projections for the coming year. This year the conference will be taking place online, with a streamlined programme.

The main panel session will explore the impact of COVID-19 on the healthcare industry in 2020 and beyond – from operational learnings and clinical trial progress, to the investment landscape and changing public perception of the industry. The panellists represent the full range of the industry:


  • Moderator: Josh Schimmer, Biotech Equity Research Analyst, Evercore ISI
  • Hugo Fry, Managing Director, Sanofi UK
  • George Goldsmith, Chairman, Chief Executive Officer and Co-Founder, COMPASS Pathways
  • Rachel Mears, Partner, Jeito Capital
  • Linden Thomson, Lead Manager, AXA Framlington Biotech Fund
  • Anne E. White, Senior Vice President of Eli Lilly and Company and President of Lilly Oncology
  • Professor Tom Wilkinson, Professor of Respiratory Medicine University of Southampton, Co-Founder, my mHealth; Trial Chief Investigator of Synairgen’s SNG001


Following the panel, Genmab’s President & Chief Executive Officer Jan van de Winkel will be interviewed by Clive Cookson, Science Editor of the Financial Times. Jan will share his insights from 10 years at the helm of Genmab and how the company has learnt to adapt in light of all the challenges posed by the pandemic.

 More than 380 international healthcare executives from across the industry are registered to attend. The webinar starts at 2pm GMT (3pm CET/9am EST). The online platform will enable delegates to pose questions throughout the event.


The conference will take place on Intrado’s webinar platform. Registration is still possible via this link, or for more information, please contact: admincsc@consilium-comms.com.


Conference programme (times in GMT):

2:00pm – 2:15pm 

Welcome and introductions

2:15pm – 3:15pm

Panel: The impact of COVID-19 on the future of healthcare

3:15pm – 3:55pm

Fireside chat: The FT’s Clive Cookson speaks to Jan van de Winkel, President & Chief Executive Officer, Genmab

3:55pm – 4:00pm

Concluding remarks


“In an extraordinarily challenging environment it has been fascinating to see how the industry has persevered and adapted, and I’m looking forward to hearing from today’s speakers on what they have learnt through the process."

Mary-Jane Elliott

Managing Partner of Consilium Strategic Communications

“I’d like to take this opportunity to say how proud I am of Consilium’s resilience and our staff’s exceptional work despite these challenges. As always, I thank our staff and clients for their constant support and feel proud to be operating in the healthcare sector where our advisory work is in such high demand.”

Mary-Jane Elliott

Managing Partner of Consilium Strategic Communications


For more information, please contact:


Consilium Strategic Communications

Mary-Jane Elliott / Amber Fennell

Tel: +44(0)20 3709 5700



Follow us: @consiliumhc


About Consilium Strategic Communications

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.


About Citi

Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi.


About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has a dedicated, international practice group of 40+ life sciences professionals across Europe, US and China. We are trusted counsel to almost 1,800 public and private life sciences company clients worldwide, including 50% of the NASDAQ Biotechnology Index. The London team works with pharmaceutical, biotechnology and healthcare companies on collaborations, M&A, growth capital, public offerings and other negotiated transactions, as well as on a wide range of transactional, IP, licensing, regulatory and competition matters within the sector. Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.


About Stifel

Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC and Century Securities Associates, Inc. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and

related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/investor-relations/press-releases.

Back to previous page